M. ERIC GERSHWIN, M.D.
This content is PDF only. Please click on the PDF icon to access.
In two decades, immunology has expanded with astounding speed: the decade of the lymphocyte (1960s) and the decade of genetic control of immune responsiveness (1970s). The 1980s will probably be the decade of monoclonal antibodies. During this period of growth and differentiation, rheumatology has also developed exponentially by taking advantage of this new knowledge. Progress in immunologically mediated rheumatic diseases has been both substantial and gratifying; there has generally been only a short lag between discoveries in basic immunology to their being applied by rheumatologists in in-vitro and in-vivo models of clinical immunologic disease. Increased knowledge and refinement of data
GERSHWIN ME. Slow Progress with Scleroderma. Ann Intern Med. 1982;97:776–778. doi: https://doi.org/10.7326/0003-4819-97-5-776
Download citation file:
Published: Ann Intern Med. 1982;97(5):776-778.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use